Collaboration aims to identify biomarkers predictive of treatment response across multiple cancer types using 10x’s single cell and spatial platforms PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Lausanne University Hospital (CHUV), one of Switzerland’s leading academic […]
CAMARILLO, Calif. — PBS Biotech, a leader in advanced cell therapy manufacturing technologies, today announced its membership in Organoid COMMONS. As a member of this industry-first consortium, PBS Biotech will collaborate with biopharma pioneers to establish the biomanufacturing standards and scalable frameworks required to transition organoid technologies from early-stage drug discovery to commercial-scale application. Organoid […]
Sale of Mass Cytometry Business to Multiplex Bio Ensures Full Continuity of CyTOF and Hyperion Product Lines, Customer Relationships, Dedicated Team and Continued Investment in Next Generation Multiplex Platforms Receives Approximately $30 Million in Negotiated Buyout Related to Contingent Consideration Obligations From Illumina’s Acquisition of SomaLogic Business BOSTON, Mass. — Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the […]
Financing includes a $17 million senior credit facility from BOK Financial and $8 million in equity from existing investors and global single-family offices. SAN FRANCISCO — Excedr, Inc. (“Excedr” or the “Company”), a leading provider of full-service laboratory equipment leasing solutions for the life sciences and healthcare industries, today announced the closing of $25 million […]
Yokohama, Japan / Suzhou, China – REPROCELL Inc., a global provider of clinical-grade iPSC technologies and regenerative medicine solutions, today announced a strategic collaboration with WEIPU Biotechnology Co., Ltd., a biotechnology company based in Suzhou, China, to support cell therapy developers in China with access to high-quality clinical starting materials and complementary biological testing services. […]
WALTHAM, Mass. — Nova Biomedical today announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. This expands Nova Biomedical’s capabilities in cell line development and strengthens its ability to support biopharmaceutical workflows from early development through manufacturing. NanoCellect® WOLF G2® cell sorting platform introduces gentle, microfluidic-based cell selection and isolation, complementing […]
Technology License Partnership provides Genentech access to MaxCyte’s portfolio of platform technologies across research, development, and manufacturing workflows ROCKVILLE, Md. — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced that it has entered into a technology license partnership […]
Partnership combines Sirona Dx‘s technology-agnostic spatial biology expertise with Parhelia‘s Spatial Station platform to improve reproducibility, increase throughput, and reduce costs across spatial biology workflows. ASHLAND, Ore. and PORTLAND, Ore. — Parhelia Biosciences and Sirona Dx today announced a strategic partnership aimed at advancing the adoption of spatial biology in translational research, clinical trials, and precision health […]
Highlights combined company’s strong financial position with over $900 million expected at closing, Treeline’s deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expected new program clinical starts Includes headline Phase 1 monotherapy data for TLN-121 in relapsed or refractory lymphomas with overall response rate of 84%, complete response rate of 32% and no […]
Adam Brown has been appointed Managing Director, assuming responsibility for the day-to-day leadership of the business As part of the transition, Richard Brown will become Chairman after 26 years as Managing Director, while John Clapham will continue supporting the company in his role as Founder. The changes reflect a planned succession process that combines continuity, […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
